Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution

Artificial blood for clinical use is not yet available therefore, we previously developed artificial oxygen carriers (capsules) and showed their functionality in vitro and biocompatibility in vivo. Herein, we assessed the functionality of the capsules in vivo in a normovolemic hemodilution rat-model...

Descripción completa

Detalles Bibliográficos
Autores principales: Wrobeln, Anna, Jägers, Johannes, Quinting, Theresa, Schreiber, Timm, Kirsch, Michael, Fandrey, Joachim, Ferenz, Katja B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371727/
https://www.ncbi.nlm.nih.gov/pubmed/32686717
http://dx.doi.org/10.1038/s41598-020-68701-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7371727/
https://www.ncbi.nlm.nih.gov/pubmed/32686717
http://dx.doi.org/10.1038/s41598-020-68701-z

Ejemplares similares